MedTrace Logo

PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome

NCT04811287 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-04-30

Study results available
· View outcomes & findings →

Summary

This study assesses the potential benefit of adjuvant platelet-rich plasma (PRP) with carpal tunnel release (CTR) for patients with severe carpal tunnel syndrome (CTS). CTR is a rather common procedure performed and seems to be quite effective for those with moderate CTS, but a number of patients with severe CTS do not have quite the same response post-CTR. The investigators will recruit patients who fall into the severe CTS category and compare CTR with and without adjuvant PRP to see if PRP can improve outcomes of this common surgery.

Conditions

  • Carpal Tunnel Syndrome
  • PRP

Interventions

DEVICE

Carpal Tunnel Release with Platelet-Rich Plasma

CTR is performed with adjuvant PRP placed intra-operatively.

PROCEDURE

Carpal Tunnel Release without Platelet-Rich Plasma

CTR is performed without adjuvant PRP placed intra-operatively.

Sponsors & Collaborators

  • Michael Fredericson, MD

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2025-03-01
Completion
2025-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04811287 on ClinicalTrials.gov